Immunization of mice with β2glycoprotein 1 (β2GP1) induces production of antiphospholipid (aPL) antibodies, which were shown to have thrombus enhancing properties in an experimental mouse model, indicating that these antibodies are thrombogenic in vivo. To determine whether the thrombogenic effect of murine antiphospholipid antibodies is due to their aPL or their anti-β2GP1 activity, we injected mice with murine monoclonal anticardiolipin (aCL) and anti-β2GP1 antibodies. Effects of these antibodies on thrombus formation, was evaluated utilizing a mouse model which enables kinetics of thrombus formation to be studied. The results of this study showed that the size of the thrombus in animals injected with murine aCL antibodies was larger than that in control groups. There was no difference in thrombus kinetics between anti-β2GP1 injected mice and controls, suggesting that the thrombogenic effect of aPL antibodies is not related to their anti-b2GP1 activity alone. Mice receiving monoclonal antibodies with both aCL and anti-β2GP1 activity, also increase thrombus size when compared with controls. These data indicate that murine aCL, but not anti-β2GP1, antibodies are thrombogenic in vivo.
Hughes GRV , Harris EN , Gharavi AE . The anticardiolipin syndrome . J Rheumatol1986; 13: 486–489 .
4.
Lockshin MD et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus . N Engl J Med1985; 313: 152–156 .
5.
Sammaritano LR , Gharavi AE , Lockshin MD . Antiphospholipid antibody syndrome: immunological and clinical aspects . Semin Arthur Rheum1990; 20: 81–96 .
6.
Harris EN , Pierangeli SS . Antiphospholipid antibodies and anti-phospholipid syndrome . Springer Semin Immunopathol1994; 16: 223–245 .
7.
McNeil HP , Simpson RJ , Chesterman CN , Krilis S . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2 glycoprotein I (apolipoprotein H) . Proc Natl Acad Sci USA1990; 87: 4120–4124 .
8.
Galli M et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor . Lancet1990; 336: 1544–1547 .
9.
Matsuura E , Igarashi Y , Fujimoto M . Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor . Lancet1990; 336: 1547-1547 .
10.
Gharavi AE , Sammaritano LR , Wen J , Elkon KB . Induction of antiphospholipid autoantibodies by immunization with β2glycoprotein 1 . J Clin Invest1992; 1105–1109 .
11.
Pierangeli SS , Davis SA , Harris EN . Induction of phospholipid binding antibodies in mice and rabbits by immunization with human b2glycoprotein 1 or anticardiolipin antibodies . Clin Exp Immunol1993; 93: 269–272 .
12.
Matsuura E et al. Anticardiolipin antibodies recognize β2glycoprotein 1 structure altered by interacting with an oxygen modified solid phase surface . J Exp Med1994; 179: 457–462 .
13.
Schousboe I . β2glycoprotein 1: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway . Blood1985; 66: 1986–1991 .
14.
Nimpf J , Bevers EM , Bomans PHH , Till U . Prothrombinase activity of human platelets is influenced by β2glycoprotein 1 . Biochem Biophys Acta1986; 884: 142–144 .
15.
Nimpf J , Wurm H , Kostner GM . β2glycoprotein 1 (apo H) inhibits the release reaction of human platelets during ADP-induced aggregation . Atherosclerosis1987; 63: 109–114 .
16.
Roubey RAS . Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulant and other ‘antiphospholipid’ autoantibodies . Blood1994; 84: 2854–2867 .
17.
Garcia C et al. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with β2GP1 . Am J Reprod Immunol1997; 37: 118–124 .
18.
Kohler G , Milstein C . Continuous culture of fused cells secreting antibody to predefined specificity . Nature1975; 256: 495–497 .
19.
Wurm H . β2glycoprotein-1 (apolipoprotein H) interaction with phospholipid vesicles . Int J Biochem1984; 16: 511–515 .
20.
Exner T . Comparison of two simple tests for the lupus anticoagulant . Am J Clin Pathol1985; 83: 215–218 .
21.
Stockmans F et al. Continuous quantitative monitoring of mural thrombus kinetics in the crushed rat femoral vein . Thromb Haemost1991; 65: 425–431 .
22.
Pierangeli SS et al. Effect of human IgG antiphospholipid on an in vivo thrombosis model in mice . Thromb Haemost1994; 71: 670–674 .
23.
Pierangeli SS et al. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the Antiphospholipid Syndrome . Thromb Haemost1995; 74: 1361–1367 .
24.
Pierangeli SS et al. Thrombogenic properties of murine anti cardiolipin antibodies induced by β2glycoprotein 1 and human 1 immunoglobulin G antiphospholipid antibodies . Circulation1996; 94: 1746–1751 .
25.
Matsuuda Y , Shiroishi T , Moriwak K , Natsuume-Sakai S . Molecular cloning of mouse β2GP1 and mapping of the gene to chromosome 11 . Genomics1992; 13: 1082–1087 .
26.
Steinkasserer A , Estaller C , Weiss S , Sim RB , Day AJ . Human b2glycoprotein-1 molecular analysis of DNA and amino acid polymorphism . Biochem J1991; 277: 387–391 .
27.
Pierangeli SS , Harris EN , Davis DA , De Lorenzo G . β2Glycoprotein 1 enhances cardiolipin binding activity but is not the target antigen for antiphospholipid antibodies . Br J Haematol1992; 82: 565–570 .
28.
Sammaritano LR , Lockshin MD , Gharavi AE . Antiphospholipid antibodies differ in cofactor requirement . Lupus1992; 1: 51–56 .
29.
Martinuzzo ME , Forastiero RR , Carreras LO . Anti-β2glycoprotein 1 antibodies: detection and association with thrombosis . Br J Haematol1995; 89: 397–402 .
30.
Gharavi AE et al. Do patients with antiphospholipid syndrome have antibodies to β2glycoprotein I?J Lab Clin Med1993; 122: 426–431 .
31.
Harris EN , Pierangeli SS , Barquinero J , Ordi Ros J . Anticardiolipin antibodies and binding of anionic phospholipids and serum proteins . Lancet1990; 336: 505–506 .
32.
Simantov R et al. Activation of Cultural Vascular Endothelial Cells by Antiphospholipid Antibodies . J Clin Invest1995; 96: 2211–2219 .
33.
Del Papa N et al. Characterization of anti-endothelial cell antibodies in antiphospholipid syndrome. In: Molecular Basis of Human Diseases. Polli EE (ed.) Elsevier Science Publishers: Amsterdam , pp 67–73.
34.
Arvieux J , Roussel B , Pouzol P , Colomb MG . Platelet activating properties of murine monoclonal antibodies to β2glycoprotein I . Thromb Haemost1993; 70: 336–341 .
35.
Goldsmith GH et al. Inhibition of prothrombin activation by antiphospholipid antibodies and 2glycoprotein 1 . Br J Haematol1995; 87: 548-548 .
36.
McCrae KR et al. Detection of anti-endothelial cell reactive immunoglobulin in patients with anti-phospholipid antibodies . Br J Haematol1991; 79: 595–605 .
37.
Campbell AE , Pierangeli SS , Wellhausen S , Harris EN . Comparison of the effect of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation . Thromb Haemost1995; 73: 519–524 .
38.
Cleve H , Rittner C . Further family studies on the genetic control of b2glycoprotein-1 concentration in human serum . Humangenetik1969; 9: 93–97 .
